European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II
(2008) In European Urology 53(3). p.497-513- Abstract
- Objectives: The first consensus report that had been presented by the European Germ Cell Cancer Consensus Group (EGCCCG) in 2004 has found widespread approval by many colleagues throughout the world. In November 2006, the group met a second time under the auspices of the Department of Urology of the Amsterdam Medical Center, The Netherlands. Methods: Medical oncologists, urologic surgeons, radiation oncologists as well as pathologists from several European countries reviewed and discussed the data that had emerged since the 2002 conference and incorporated the new data into updated and revised guidelines. As for the first meeting the methodology of evidence-based medicine (EBM) was applied. The results of the discussion were compiled by... (More)
- Objectives: The first consensus report that had been presented by the European Germ Cell Cancer Consensus Group (EGCCCG) in 2004 has found widespread approval by many colleagues throughout the world. In November 2006, the group met a second time under the auspices of the Department of Urology of the Amsterdam Medical Center, The Netherlands. Methods: Medical oncologists, urologic surgeons, radiation oncologists as well as pathologists from several European countries reviewed and discussed the data that had emerged since the 2002 conference and incorporated the new data into updated and revised guidelines. As for the first meeting the methodology of evidence-based medicine (EBM) was applied. The results of the discussion were compiled by the writing committee. All participants have agreed to this final update. Results: The second part of the consensus paper includes the treatment of metastasised disease, residual tumour resection, salvage therapy, follow-up, and late toxicities. Conclusions: Whereas the vast majority of the recommendations made in 2004 remain valid 3 yr later, refinements in the treatment of early-stage as well as of advanced-stage testicular cancer have emerged from clinical trials. Despite technical improvements, expert clinical skills will continue to be one of the major determinants for the prognosis of patients with germ cell cancer. in addition, the particular needs of testicular cancer survivors have been acknowledged. (C) 2007 European Association of Urology. Published by Elsevier B.V. All rights reserved. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1193396
- author
- organization
- publishing date
- 2008
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- treatment in metastatic, follow-up, salvage therapy, germ cell tumors
- in
- European Urology
- volume
- 53
- issue
- 3
- pages
- 497 - 513
- publisher
- Elsevier
- external identifiers
-
- wos:000253619800007
- scopus:38949176745
- pmid:18191015
- ISSN
- 1873-7560
- DOI
- 10.1016/j.eururo.2007.12.025
- language
- English
- LU publication?
- yes
- id
- b2bc02dd-ba4b-4849-8738-415a4e589ec3 (old id 1193396)
- date added to LUP
- 2016-04-01 13:35:03
- date last changed
- 2022-04-14 01:58:56
@article{b2bc02dd-ba4b-4849-8738-415a4e589ec3,
abstract = {{Objectives: The first consensus report that had been presented by the European Germ Cell Cancer Consensus Group (EGCCCG) in 2004 has found widespread approval by many colleagues throughout the world. In November 2006, the group met a second time under the auspices of the Department of Urology of the Amsterdam Medical Center, The Netherlands. Methods: Medical oncologists, urologic surgeons, radiation oncologists as well as pathologists from several European countries reviewed and discussed the data that had emerged since the 2002 conference and incorporated the new data into updated and revised guidelines. As for the first meeting the methodology of evidence-based medicine (EBM) was applied. The results of the discussion were compiled by the writing committee. All participants have agreed to this final update. Results: The second part of the consensus paper includes the treatment of metastasised disease, residual tumour resection, salvage therapy, follow-up, and late toxicities. Conclusions: Whereas the vast majority of the recommendations made in 2004 remain valid 3 yr later, refinements in the treatment of early-stage as well as of advanced-stage testicular cancer have emerged from clinical trials. Despite technical improvements, expert clinical skills will continue to be one of the major determinants for the prognosis of patients with germ cell cancer. in addition, the particular needs of testicular cancer survivors have been acknowledged. (C) 2007 European Association of Urology. Published by Elsevier B.V. All rights reserved.}},
author = {{Krege, Susanne and Beyer, Joerg and Souchon, Rainer and Albers, Peter and Albrecht, Walter and Alyaba, Ferran and Bamberg, Michael and Bodrogi, Istvan and Bokemeyer, Carsten and Cavallin-Ståhl, Eva and Classen, Johannes and Clemm, Christoph and Cohn-Cedermark, Gabriella and Culine, Stephane and Daugaard, Gedske and De Mulder, Pieter H. M. and De Santis, Maria and de Wit, Maike and de Wit, Ronald and Derigs, Hans Guenter and Dieckmann, Klaus-Peter and Dieing, Annette and Droz, Jean-Pierre and Fenner, Martin and Fizazi, Karim and Flechon, Aude and Fossa, Sophie D. and del Muro, Xavier Garcia and Gauler, Thomas and Geczi, Lajos and Gerl, Arthur and Germa-Lluch, Jose Ramon and Gillessen, Silke and Hartmann, Joerg T. and Hartmann, Michael and Heidenreich, Axel and Hoeltl, Wolfgang and Horwich, Alan and Huddart, Robert and Jewett, Michael and Joffe, Johnathan and Jones, William G. and Kisbenedek, Lasszlo and Klepp, Olbjorn and Kliesch, Sabine and Koehrmann, Kai Uwe and Kollmannsberger, Christian and Kuczyk, Markus and Laguna, Pilar and Galvis, Oscar Leiva and Loy, Volker and Mason, Malcolm D. and Mead, Graham M. and Mueller, Rolf and Nichols, Craig and Nicolai, Nicola and Oliver, Tim and Ondrus, Dalibor and Oosterhof, Gosse O. N. and Paz-Ares, Luis and Pizzocaro, Giorgio and Pont, Joerg and Pottek, Tobias and Powles, Tom and Rick, Oliver and Rosti, Giovanni and Saluioni, Roberto and Scheiderbauer, Jutta and Schmelz, Hans-Ulrich and Schmidberger, Heinz and Schmoll, Hans-Joachim and Schrader, Mark and Sedlmayer, Felix and Skakkebaek, Niels E. and Sohaib, Aslam and Tjulandin, Sergei and Warde, Padraig and Weinknecht, Stefan and Weissbach, Lothar and Wittekind, Christian and Winter, Eva and Wood, Lori and von der Maase, Hans}},
issn = {{1873-7560}},
keywords = {{treatment in metastatic; follow-up; salvage therapy; germ cell tumors}},
language = {{eng}},
number = {{3}},
pages = {{497--513}},
publisher = {{Elsevier}},
series = {{European Urology}},
title = {{European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II}},
url = {{http://dx.doi.org/10.1016/j.eururo.2007.12.025}},
doi = {{10.1016/j.eururo.2007.12.025}},
volume = {{53}},
year = {{2008}},
}